LSE:RB 16 March 2026 - 12 June 2026

Reckitt climbs after £1 billion buyback but trades under offer price

Reckitt climbs after £1 billion buyback but trades under offer price

Reckitt Benckiser Group shares traded up 1.25% at 4,713 pence in London early Wednesday. Shares still sat 2.9% below the £48.55 average the company paid at the end of its recent buyback. Reckitt bought back 11.12 million shares from March 9 through June 15, closing a £1 billion buyback. By 1303 BST, about 443,000 shares changed hands, compared with the usual 2.02 million daily. During the 67 London sessions in that stretch, the last trades averaged 166,000 shares per day. That’s about 8% of Reckitt’s usual daily volume. It wasn’t most of the trading, but now the steady buyer is gone.
June 24, 2026
Reckitt Benckiser gains as investors look at buyback and dividend after hitting 52-week low

Reckitt shares gain as buyback gives support before July update

Reckitt Benckiser Group plc was up 1.38% at 4,643p in afternoon London trade Friday. The FTSE 100 added 0.93%. The Dettol, Durex and Nurofen owner was still moving after its latest daily report on the share buyback. Google Finance data showed Reckitt far from its 52-week high of 6,514p, so investors seem cautious even with Friday’s move higher. Reckitt said in a filing it bought 194,500 ordinary shares on June 11, paying an average of 4,615.90p each. The company is keeping the repurchased stock in treasury, not cancelling it. Treasury shares cut the total voting shares and can help EPS since earnings are spread over fewer shares. Reckitt now holds 38,688,655 shares in treasury and has 635,317,097 ordinary shares outstanding,
June 12, 2026
Reckitt Benckiser’s AI Push Faces a Bigger Test After Dettol Maker’s Growth Miss

Reckitt Shares Dip as Buyback Does Little to Ease Margin Concerns

Reckitt Benckiser shares slipped late Monday in London after the company announced a new buyback and a minor euro bond tap, which failed to dispel worries over weak trading and pressure on margins. The stock lost 1.7% to 4,471p by 15:56 BST. The FTSE 100 was flat to a touch stronger. Reckitt is in the middle of a reset. The maker of Durex, Dettol and Lysol has been giving cash back to shareholders, but the stock is still well off its January high. Investors want to know if the company can grow as a smaller group without hitting its margin in the process.
June 8, 2026
Reckitt Shares Recover Even as Uncertainty Lingers

Reckitt Shares Recover Even as Uncertainty Lingers

Reckitt Benckiser Group shares finished higher on Friday, up 1.88% at £45.49, while the FTSE 100 rose 0.07%. Despite the late-week gain, Reckitt Benckiser still closed down about 0.9% from last week's £45.91 finish, leaving the week in the red. That’s in play because London is closed for the weekend, leaving investors with two days to think about a small rebound versus bigger troubles. Reckitt remains down over 30% from its January 52-week high, with the market still reacting to weak first-quarter sales and risk to margins from costs.
June 6, 2026
Reckitt Shares Bounce on AI Effort, Investors Hold Off Ahead of AGM

Reckitt Shares Bounce on AI Effort, Investors Hold Off Ahead of AGM

Reckitt Benckiser Group finished up on Friday, with shares rising after the maker of Dettol and Durex held an investor event focused on artificial intelligence and product development. Even so, the stock stayed down for the week. Reckitt closed Friday at 4,597p, rising 51p, or 1.12%. Shares hit that same level earlier in the session. The stock is down about 1.6% for the week, with Friday’s climb outpacing a soft FTSE 100. Reckitt ended at 4,671p on May 8.
May 16, 2026
Reckitt Buyback Grows as Shares Skid Near a One-Year Low

Reckitt Buyback Grows as Shares Skid Near a One-Year Low

Reckitt Benckiser Group plc snapped up 208,000 of its own shares, sticking with its capital-return strategy as the shares hover close to a one-year low, according to a regulatory filing published Wednesday. The Dettol, Durex and Mucinex owner bought the stock from Deutsche Bank AG, London Branch, paying between 4,534 pence and 4,581 pence per share. The repurchased shares go into treasury, so they'll stay on Reckitt’s books instead of moving to outside holders. Timing’s key here. Reckitt’s buyback stands out as a rare source of support for shareholders, especially after a shaky first quarter soured sentiment on the consumer-health group’s 2026 goals.
May 13, 2026
Reckitt Benckiser’s China Speed Bet Puts Durex, Lysol Maker Back in Market Focus

Reckitt Benckiser’s China Speed Bet Puts Durex, Lysol Maker Back in Market Focus

Kris Licht, CEO of Reckitt Benckiser Group plc, is framing China’s rapid shift to video-driven ecommerce as a key trial for the company’s broader strategy overhaul. Calling it “the most profound channel shift” he’s witnessed, Licht said Reckitt “pivoted hard” as shoppers left physical stores for their phones. The numbers are stark: ecommerce and social commerce — mostly through video and social apps — now account for roughly 80% of Reckitt’s sales in China, a steep climb from 30% six years back. China revenue is approaching £1 billion, with 11 consecutive quarters of double-digit gains, Licht told Semafor in an interview. Timing’s key here. Reckitt is out to convince investors that digital sales, quicker product cycles, and artificial intelligence aren’t
May 9, 2026
Reckitt Benckiser Buyback Puts Share Count in Focus After Bruising Q1

Reckitt Benckiser Buyback Puts Share Count in Focus After Bruising Q1

Reckitt Benckiser Group plc now lists 640,814,501 votes as its current shareholder base, according to a new regulatory filing. The updated figure gives investors a new reference for UK stake disclosures, with the company continuing its share buyback program following a disappointing first quarter. The timing of the update is key, with Reckitt aiming to demonstrate capital discipline as investors juggle concerns over sluggish sales, margin headwinds, and unpredictable consumer trends. Share buybacks tend to lift earnings per share by trimming the share count used for economic and voting rights—although treasury shares, held internally, don’t come with any voting power.
May 2, 2026
Reckitt Benckiser Durex Headache Deepens as China Price Scare Follows Weak Quarter

Reckitt Benckiser Durex Headache Deepens as China Price Scare Follows Weak Quarter

Reckitt Benckiser Group plc is under new pressure in China, with news of rising condom prices spreading quickly online. The viral warning has sparked chatter about stockpiling, hitting one of the company’s vital growth markets only days after it posted quarterly sales that fell short of forecasts. This issue is moving front and center after China and India gave Reckitt’s emerging markets results a lift in the first quarter. Durex sales in China, though, have stalled—condoms and contraceptive pills are now hit with a 13% value-added tax, pushing up prices throughout the supply chain. Karex Bhd, which makes more condoms than anyone and counts Durex and Trojan among its customers, says it may hike prices 20% to 30% if supply
April 25, 2026
Reckitt Benckiser Share Price Jumps After Morgan Stanley Upgrade as Investors Revisit Selloff

Reckitt Benckiser Share Price Jumps After Morgan Stanley Upgrade as Investors Revisit Selloff

Reckitt Benckiser ended Monday up 2.4% at 5,484 pence, landing it among the FTSE 100’s top gainers. Morgan Stanley lifted its rating to “overweight” and issued a price target of 6,300 pence. The rebound does little to erase Reckitt’s 15.8% loss for the month, or the 12.3% drop since Jan. 1. Monday’s uptick recoups just a fraction of last week’s selloff. On March 5, shares tumbled over 6% when the company stopped short of offering margin guidance and pointed to profit pressure ahead.
March 16, 2026